Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

Condition:   Central Nervous System Tumors Interventions:   Drug: Avelumab;   Drug: Lenvatinib Sponsors:   EMD Serono Research & Development Institute, Inc.;   Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials